India falters in administering the second dose
No new variant in India According to INSACOG, AY4.2, a Delta variant sublineage, which is slowly increasing in proportion to reported cases in the U.K., is “very infrequent” in India.…
Category: Bharat Biotech International
Should healthy children be vaccinated on priority?
The National Immunization Technical Advisory Group (NTAGI) Chairperson Dr. N.K. Arora had said children with comorbidities will be prioritised to receive the vaccine “immediately and healthy children can be immunised…
India scripts history with one billion vaccine doses administered
What makes the accomplishment even more outstanding is the fact that the vaccination programme had targeted adults. Unlike the well-established universal immunisation programme which administers a basket of vaccines to…
Amidst shortage, allotting 25% of vaccines produced to private hospitals will aggravate vaccine inequity
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore and Dr. Chandrakant Lahariya, physician-epidemiologist and a vaccines and health systems expert discuss the ethical and structural challenges…
Two vaccine doses offer 77% protection against hospitalisation, CMC Vellore study finds
The study has been published in the journal Mayo Clinic Proceedings. “Our study shows that COVID-19 vaccines have a great benefit in reducing infection and severity of disease. Vaccination helps…
Covaxin offers protection against beta and delta variants, says study
The study evaluated the neutralisation potential in people vaccinated with Covaxin and found that there was a 3- and 2.7-fold reduction in neutralisation titers against the beta (B.1.351) and delta…
Study finds Covishield produces more antibodies than Covaxin, but scientists point out serious flaws with the preprint
The seropositivity rates and the median antibody titre against spike protein was “significantly higher” in those vaccinated with Covishield compared with Covaxin, according to a preprint posted in medRxiv. Preprints…
Vaccine shortage will affect all eligible groups
The two private vaccine manufacturers — Serum Institute and Bharat Biotech — are required to supply 50% of vaccine produced to the Central government and the balance to State governments…
Science Chronicle 